Billionaires Pay Record Sums for Dinosaur Bones Science Cannot Study
A T. rex named Gus sold for a record $50.1 million this month, but the market’s earlier billionaire showcase fossil, Shen, never actually sold in 2022.
Prior to the position, Ishan was senior vice president, strategy & development for Cumbernauld-media Company since April 2013. He joined the Company in 2004 and has served in several corporate developments, business development and strategic planning roles for three chief executives. During that time, he helped transform the Company from a traditional U.S. media conglomerate into a global digital subscription service, unified by the journalism and brand of Cumbernauld-media.
A T. rex named Gus sold for a record $50.1 million this month, but the market’s earlier billionaire showcase fossil, Shen, never actually sold in 2022.
A New Jersey homeowner’s gloves and foil preserved the Hillsborough meteorite long enough for scientists to find asteroid brine chemistry never seen before.
Iceland’s sold-out eclipse rush already resembles the Faroe Islands’ 2015 surprise, when actual turnout more than doubled the original tourism forecasts.
NASA traced 1998 SH2’s drifting orbit to hidden gas jets, confirming a dark comet and pointing to dozens more hiding in near-Earth catalogs.
BPCL’s Bharatgas Lite ZIP joins HPCL’s Instamart tie-up in a race for LPG’s digital front door, built on distributors still seeking a raise.
Toyota’s Hilux launches July 28, opening a five-SUV rollout through 2028 that leans, for the first time, on Maruti Suzuki’s own hybrid engineering.
Brussels’ July 16 orders push Google’s EU antitrust bill past 11 billion euros, and Apple’s rejected Siri fix shows what Google risks next.
Samsung’s July 22 Unpacked reveals a pricier Fold 8 Ultra and Gemini glasses entering a market still shadowed by Meta’s privacy lawsuit.
Etihad, Emirates and Air Arabia canceled UAE-Kuwait flights after fresh missile strikes, as war-risk insurance quietly reshapes Gulf airline schedules into autumn.
Bacteria aboard the ISS have grown drug resistant for decades. A new Mars simulation study shows the same risk could intensify for future astronaut crews.